-transparent.png){kind=logo}
Tumor biopsies from 68 patients with malignant melanoma were assessed for estrogen receptor (ERc) binding, and 32 of these for progesterone receptor (PRc) binding. Twenty-five patients (37%) had ERc greater than or equal to 5 fmols/mg protein; 14 patients (44%) had PRc greater than or equal to 10 fmols/mg of protein. There was no significant difference between the sexes in relation to the presence or absence of ERc or PRc. The tumor ERc and PRc levels did not predict the survival of these patients. Seventeen patients were treated with tamoxifen; three female patients had objective responses. Two of the patients with complete response had ERc levels of 4.3 and 19 fmols/mg tumor cytosol protein, while the third patient had no detectable ERc.
C P Karakousis, and
R E Lopez, and
H S Bhakoo, and
F Rosen, and
R Moore, and
M Carlson
August 1981,
Lancet (London, England),
C P Karakousis, and
R E Lopez, and
H S Bhakoo, and
F Rosen, and
R Moore, and
M Carlson
January 1985,
Pathologie-biologie,
C P Karakousis, and
R E Lopez, and
H S Bhakoo, and
F Rosen, and
R Moore, and
M Carlson
February 1987,
Archives of dermatology,
C P Karakousis, and
R E Lopez, and
H S Bhakoo, and
F Rosen, and
R Moore, and
M Carlson
January 1985,
The Journal of dermatologic surgery and oncology,
C P Karakousis, and
R E Lopez, and
H S Bhakoo, and
F Rosen, and
R Moore, and
M Carlson
December 1983,
Geburtshilfe und Frauenheilkunde,
C P Karakousis, and
R E Lopez, and
H S Bhakoo, and
F Rosen, and
R Moore, and
M Carlson
February 2014,
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
C P Karakousis, and
R E Lopez, and
H S Bhakoo, and
F Rosen, and
R Moore, and
M Carlson
October 1980,
Cancer,
C P Karakousis, and
R E Lopez, and
H S Bhakoo, and
F Rosen, and
R Moore, and
M Carlson
May 1981,
Cancer research,
C P Karakousis, and
R E Lopez, and
H S Bhakoo, and
F Rosen, and
R Moore, and
M Carlson
January 1984,
Gynecologic and obstetric investigation,
C P Karakousis, and
R E Lopez, and
H S Bhakoo, and
F Rosen, and
R Moore, and
M Carlson
February 2004,
Gynecologic oncology,
